lung cancer
Conditions
Interventions
accept targeted adjuvant therapy:None
not accept targeted adjuvant therapy:None
Sponsors
Zhejiang cancer Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Accept radical surgical resection; The pathological type is adenocarcinoma; Pathological staging IA stage (AJCC 8th edition staging); Accompanied by at least one pathological high-risk factor: containing high-grade pathological types (micropapillary, solid, and complex glandular), positive for intracavitary dissemination (STAS), vascular invasion, bronchial invasion, and nerve invasion; There is an EGFR sensitive mutation present;
Exclusion criteria
Exclusion criteria: The pathological type is mixed with other types of lung cancer components besides adenocarcinoma; Received neoadjuvant therapy before surgery; Received adjuvant radiotherapy after surgery; The patient has received treatment for other malignant tumors within the past 5 years; Other researchers believe that it is not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| prognosis;Progression free survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival rate; | — |
Countries
China
Contacts
Public ContactJian Zeng
Zhejiang cancer hospital
Outcome results
None listed